Letter to the Editor: Role of Ketamine in Vaso-Occlusive Crisis of Sickle Cell Disease.
作者信息
Raghuraman M S
机构信息
Department of Anesthesiology and Pain Medicine, Sree Balaji Medical College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
出版信息
Saudi J Med Med Sci. 2022 Jan-Apr;10(1):81-82. doi: 10.4103/sjmms.sjmms_234_21. Epub 2022 Jan 17.
Abstract
摘要
相似文献
1
Letter to the Editor: Role of Ketamine in Vaso-Occlusive Crisis of Sickle Cell Disease.致编辑的信：氯胺酮在镰状细胞病血管闭塞性危机中的作用
Saudi J Med Med Sci. 2022 Jan-Apr;10(1):81-82. doi: 10.4103/sjmms.sjmms_234_21. Epub 2022 Jan 17.
2
Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.镰状细胞血管闭塞危象期间氧化应激的加剧与抗带3自身抗体率降低和红细胞衍生微粒水平升高相关：一项前瞻性研究。
Br J Haematol. 2017 Mar;176(5):805-813. doi: 10.1111/bjh.14476. Epub 2016 Dec 16.
3
Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.磁共振成像评估镰状细胞血管阻塞危象期间肾脏的氧合和灌注。
Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.
4
Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.应对急性疼痛临床试验的挑战：镰状细胞病儿童和青年血管闭塞性危机的疼痛管理研究。
Clin Trials. 2016 Aug;13(4):409-16. doi: 10.1177/1740774516636573. Epub 2016 Mar 21.
5
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.沙利度胺治疗镰状细胞病患者急性疼痛危象的多中心、随机、双盲、安慰剂对照 2 期临床试验。
Lancet Haematol. 2021 May;8(5):e334-e343. doi: 10.1016/S2352-3026(21)00053-3.
6
Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.低剂量氯胺酮与吗啡治疗儿童急性重度血管闭塞性疼痛的随机对照试验。
Scand J Pain. 2018 Jan 26;18(1):19-27. doi: 10.1515/sjpain-2017-0140.
7
Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.低剂量氯胺酮输注用于镰状细胞病成人血管闭塞发作期间的辅助治疗：病例系列
J Pain Palliat Care Pharmacother. 2018 Mar;32(1):20-26. doi: 10.1080/15360288.2018.1468383. Epub 2018 May 23.
8
Clinical and Laboratory Predictors of Painful Vaso-Occlusive Crisis Among Sickle Cell Disease Patients: A Single-Center Study in Saudi Arabia.镰状细胞病患者疼痛性血管闭塞危象的临床和实验室预测因素：沙特阿拉伯的一项单中心研究
Cureus. 2021 May 12;13(5):e14980. doi: 10.7759/cureus.14980.
9
Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.小儿镰状细胞病血管阻塞危象期间的亚临床心肌损伤。
Eur J Pediatr. 2018 Dec;177(12):1745-1752. doi: 10.1007/s00431-018-3231-x. Epub 2018 Sep 7.
10
Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.低剂量氯胺酮作为镰状细胞病疼痛性血管闭塞危象的潜在辅助治疗方法。
Paediatr Anaesth. 2013 Aug;23(8):684-9. doi: 10.1111/pan.12172. Epub 2013 Apr 9.
本文引用的文献
1
Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review.氯胺酮用于镰状细胞血管闭塞性危象：一项系统评价
Saudi J Med Med Sci. 2021 Jan-Apr;9(1):3-9. doi: 10.4103/sjmms.sjmms_218_20. Epub 2020 Dec 26.
2
Safety of Repeated Administration of Parenteral Ketamine for Depression.静脉注射氯胺酮重复给药治疗抑郁症的安全性。
Pharmaceuticals (Basel). 2020 Jul 13;13(7):151. doi: 10.3390/ph13070151.
3
Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study.用于住院儿童、青少年和青年疼痛管理的亚麻醉剂量氯胺酮：一项单中心队列研究。
J Pain Res. 2017 Apr 5;10:787-795. doi: 10.2147/JPR.S131156. eCollection 2017.
4
Ketamine for chronic pain: risks and benefits.氯胺酮治疗慢性疼痛：风险与获益。
Br J Clin Pharmacol. 2014 Feb;77(2):357-67. doi: 10.1111/bcp.12094.
Zotero 插件